The Role of Stem Cells As Therapeutics for Ischaemic Stroke

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2024 Jan 22

PMID 38247804

Authors

Jingyuan Ya

Jessica Pellumbaj

Arshad Hashmat

Ulvi Bayraktutan

Affiliations

Soon will be listed here.

Abstract

Stroke remains one of the leading causes of death and disability worldwide. Current reperfusion treatments for ischaemic stroke are limited due to their narrow therapeutic window in rescuing ischaemic penumbra. Stem cell therapy offers a promising alternative. As a regenerative medicine, stem cells offer a wider range of treatment strategies, including long-term intervention for chronic patients, through the reparation and replacement of injured cells via mechanisms of differentiation and proliferation. The purpose of this review is to evaluate the therapeutic role of stem cells for ischaemic stroke. This paper discusses the pathology during acute, subacute, and chronic phases of cerebral ischaemic injury, highlights the mechanisms involved in mesenchymal, endothelial, haematopoietic, and neural stem cell-mediated cerebrovascular regeneration, and evaluates the pre-clinical and clinical data concerning the safety and efficacy of stem cell-based treatments. The treatment of stroke patients with different types of stem cells appears to be safe and efficacious even at relatively higher concentrations irrespective of the route and timing of administration. The priming or pre-conditioning of cells prior to administration appears to help augment their therapeutic impact. However, larger patient cohorts and later-phase trials are required to consolidate these findings.

Citing Articles

Roles and Potential Mechanisms of Endothelial Cell-Derived Extracellular Vesicles in Ischemic Stroke.

Yu X, Huang Y, Li C Transl Stroke Res. 2025; .

PMID: 39918683 DOI: 10.1007/s12975-025-01334-4.

Stem cell-derived exosomes for ischemic stroke: a conventional and network meta-analysis based on animal models.

Xu K, Zhao X, He Y, Guo H, Zhang Y Front Pharmacol. 2024; 15:1481617.

PMID: 39508049 PMC: 11537945. DOI: 10.3389/fphar.2024.1481617.

Comorbidities and Angiogenic Regulators Affect Endothelial Progenitor Cell Subtype Numbers in a Healthy Volunteer Control Group.

Rakkar K, Kadir R, Othman O, Sprigg N, Bath P, Bayraktutan U Stem Cell Rev Rep. 2024; 20(8):2336-2344.

PMID: 39186241 PMC: 11554701. DOI: 10.1007/s12015-024-10777-5.

Intersecting Pathways: The Role of Metabolic Dysregulation, Gastrointestinal Microbiome, and Inflammation in Acute Ischemic Stroke Pathogenesis and Outcomes.

Nuszkiewicz J, Kukulska-Pawluczuk B, Piec K, Jarek D, Motolko K, Szewczyk-Golec K J Clin Med. 2024; 13(14).

PMID: 39064298 PMC: 11278353. DOI: 10.3390/jcm13144258.

Advanced Nano-Drug Delivery Systems in the Treatment of Ischemic Stroke.

Zhang J, Chen Z, Chen Q Molecules. 2024; 29(8).

PMID: 38675668 PMC: 11054753. DOI: 10.3390/molecules29081848.

References

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

Yang B, Migliati E, Parsha K, Schaar K, Xi X, Aronowski J . Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke. 2013; 44(12):3463-72. PMC: 4209211. DOI: 10.1161/STROKEAHA.111.000821. View

Fang J, Guo Y, Tan S, Li Z, Xie H, Chen P . Autologous Endothelial Progenitor Cells Transplantation for Acute Ischemic Stroke: A 4-Year Follow-Up Study. Stem Cells Transl Med. 2018; 8(1):14-21. PMC: 6312444. DOI: 10.1002/sctm.18-0012. View

Singla A, Hogan W, Ansell S, Buadi F, Dingli D, Dispenzieri A . Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2013; 19(8):1233-7. PMC: 3752294. DOI: 10.1016/j.bbmt.2013.05.019. View

Khan A, Jong Huat T, Mutery A, El-Serafi A, Hadj Kacem H, Abdallah S . Significant transcriptomic changes are associated with differentiation of bone marrow-derived mesenchymal stem cells into neural progenitor-like cells in the presence of bFGF and EGF. Cell Biosci. 2020; 10:126. PMC: 7594431. DOI: 10.1186/s13578-020-00487-z. View

Losenkova K, Zuccarini M, Helenius M, Jacquemet G, Gerasimovskaya E, Tallgren C . Endothelial cells cope with hypoxia-induced depletion of ATP via activation of cellular purine turnover and phosphotransfer networks. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(5 Pt A):1804-1815. DOI: 10.1016/j.bbadis.2018.03.001. View

Abdullah Z, Bayraktutan U . Suppression of PKC-α attenuates TNF-α-evoked cerebral barrier breakdown via regulations of MMP-2 and plasminogen-plasmin system. Biochim Biophys Acta. 2016; 1862(7):1354-66. DOI: 10.1016/j.bbadis.2016.03.014. View

Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K . Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med. 2003; 9(11):1370-6. DOI: 10.1038/nm948. View

Wang F, Tang H, Zhu J, Zhang J . Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke. Cell Transplant. 2018; 27(12):1825-1834. PMC: 6300770. DOI: 10.1177/0963689718795424. View

10.

Lei J, Vodovotz Y, Tzeng E, Billiar T . Nitric oxide, a protective molecule in the cardiovascular system. Nitric Oxide. 2013; 35:175-85. DOI: 10.1016/j.niox.2013.09.004. View

11.

Yao Y . Basement membrane and stroke. J Cereb Blood Flow Metab. 2018; 39(1):3-19. PMC: 6311666. DOI: 10.1177/0271678X18801467. View

12.

Tai L, Saffery N, Chin S, Cheong S . Secretome profile of TNF-α-induced human umbilical cord mesenchymal stem cells unveils biological processes relevant to skin wound healing. Regen Med. 2023; 18(11):839-856. DOI: 10.2217/rme-2023-0085. View

13.

Correa P, Mesquita C, Felix R, Azevedo J, Barbirato G, Falcao C . Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke. Clin Nucl Med. 2007; 32(11):839-41. DOI: 10.1097/RLU.0b013e318156b980. View

14.

Lin C, Lee H, Lee S, Lee W, Cho C, Lin S . Role of HIF-1α-activated Epac1 on HSC-mediated neuroplasticity in stroke model. Neurobiol Dis. 2013; 58:76-91. DOI: 10.1016/j.nbd.2013.05.006. View

15.

Jun-Long H, Yi L, Bao-Lian Z, Jia-Si L, Ning Z, Zhou-Heng Y . Necroptosis Signaling Pathways in Stroke: From Mechanisms to Therapies. Curr Neuropharmacol. 2018; 16(9):1327-1339. PMC: 6251040. DOI: 10.2174/1570159X16666180416152243. View

16.

Watanabe T, Nagai A, Sheikh A, Mitaki S, Wakabayashi K, Kim S . A human neural stem cell line provides neuroprotection and improves neurological performance by early intervention of neuroinflammatory system. Brain Res. 2015; 1631:194-203. DOI: 10.1016/j.brainres.2015.11.031. View

17.

Savitz S, Yavagal D, Rappard G, Likosky W, Rutledge N, Graffagnino C . A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke). Circulation. 2018; 139(2):192-205. DOI: 10.1161/CIRCULATIONAHA.117.030659. View

18.

Sussman E, Steinberg G . A Focused Review of Clinical and Preclinical Studies of Cell-Based Therapies in Stroke. Neurosurgery. 2017; 64(CN_suppl_1):92-96. PMC: 5901313. DOI: 10.1093/neuros/nyx329. View

19.

Medina R, ONeill C, Sweeney M, Guduric-Fuchs J, Gardiner T, Simpson D . Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics. 2010; 3:18. PMC: 2881111. DOI: 10.1186/1755-8794-3-18. View

20.

Obernier K, Alvarez-Buylla A . Neural stem cells: origin, heterogeneity and regulation in the adult mammalian brain. Development. 2019; 146(4). PMC: 6398449. DOI: 10.1242/dev.156059. View